课题基金 / 基金详情

The role of T cell receptor avidity in determining T cell repertoires and responses

The role of T cell receptor avidity in determining T cell repertoires and responses
T 细胞受体亲合力在确定 T 细胞库和反应中的作用
批准号:
nhmrc : 350395
负责人:
Prof Nicole La Gruta
金额:
$31.51万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2008-12-31

项目摘要

项目成果

Prof Nicole La Gruta的其他基金

相似基金

相关文献

中文摘要
翻译
T细胞是免疫系统的重要组成部分。特别是CD8 T细胞,在对病毒和肿瘤的免疫反应中起着至关重要的作用,主要是通过杀死病毒感染的细胞和肿瘤细胞,以及释放炎症介质。T细胞必须被激活才能介导这种抗病毒或抗肿瘤作用,这种激活是通过T细胞表面的受体(T细胞受体)结合病原体或肿瘤片段(肽)发生的。每个个体都有一个完整的T细胞库,具有独特的T细胞受体,与不同结合强度的肽相互作用。在T细胞受到例如病毒感染的刺激后,T细胞库的一个子集将扩大并主导抗病毒免疫反应。本研究旨在研究在病毒感染期间,T细胞受体和肽之间相互作用的强度(或“亲和度”)如何影响(i) T细胞克隆是否被招募到免疫反应中,如果是,它在该反应中对其他克隆的优势地位,以及(ii) T细胞被激活的效率如何。可以预见,与不同病毒肽特异性的低亲和性T细胞群相比,具有整体高亲和性的特定病毒肽特异性T细胞群将能够更好地产生炎症介质并杀死感染细胞。预计高亲和度的种群将表现出更大的tcr多样性。此外,在肽特异性群体中,预计相对高亲和度的T细胞克隆将主导特异性反应。这项研究将有助于更好地理解促进T细胞募集和激活的因素。有了这些知识,我们将能够更好地设计疫苗,以引发最佳的T细胞对病毒感染的反应。
英文摘要
T cells are an essential component of the immune system. CD8 T cells, in particular, play a vital role in the immune response to viruses and tumors, predominantly via killing of virally infected cells and tumor cells, as well as the release of inflammatory mediators. T cells must be activated before they can mediate such anti-viral or anti-tumor effects and this activation occurs through the binding of pathogen or tumor fragments (peptides) by a receptor on the surface of T cells (T cell receptor). Each individual has an entire repertoire of T cells with unique T cell receptors which interact with peptides with varying binding strengths. After stimulation of T cells by e.g. viral infection, a subset of the T cell repertoire will become expanded and dominate the anti-viral immune response. This study aims to investigate how, during a viral infection, the strength (or 'avidity') of the interaction between the T cell receptor and the peptide influences (i) whether or not a T cell clone is recruited into the immune response and, if so, its dominance over other clones within that response, and (ii) how efficiently a T cell is activated. It is anticipated that particular virus peptide-specific T cell populations with an overall high avidity will be better able to produce inflammatory mediators and kill infected cells compared to lower avidity T cell populations specific for a different virus peptide. It is also expected that the higher avidity populations will exhibit greater diversity of TCRs. Further, within peptide-specific populations, it is anticipated that the relatively high avidity T cell clones will dominate the specific response. This study will contribute to a greater understanding of factors contributing to T cell recruitment and activation. Armed with this knowledge we will be better able to design vaccines to elicit optimal T cell responses to viral infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Lck/CD8 Association in Negatively Regulating T cell Activation
  • 批准号:
    DP230102412
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $59.91万
  • 财政年份:
    2023
  • 负责人:
    Prof Nicole La Gruta
  • 依托单位:
Exceptions Prove the Rule: How Antigen Recognition Drives T cell Activation
  • 批准号:
    DP200102776
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $41.44万
  • 财政年份:
    2020
  • 负责人:
    Prof Nicole La Gruta
  • 依托单位:
Drivers of effective T cell immunity
  • 批准号:
    FT170100174
  • 项目类别:
    ARC Future Fellowships
  • 资助金额:
    $71.24万
  • 财政年份:
    2018
  • 负责人:
    Prof Nicole La Gruta
  • 依托单位:
A molecular investigation into the naïve T cell repertoire
  • 批准号:
    DP170103631
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $38.36万
  • 财政年份:
    2017
  • 负责人:
    Prof Nicole La Gruta
  • 依托单位:
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位: